Cancers,
Journal Year:
2023,
Volume and Issue:
15(15), P. 3817 - 3817
Published: July 27, 2023
The
study
presents
‘G4-QuadScreen’,
a
user-friendly
computational
tool
for
identifying
MTDLs
against
G4s.
Also,
it
offers
few
hit
based
on
in
silico
and
vitro
approaches.
Multi-tasking
QSAR
models
were
developed
using
linear
discriminant
analysis
random
forest
machine
learning
techniques
predicting
the
responses
of
interest
(G4
interaction,
G4
stabilization,
selectivity,
cytotoxicity)
considering
variations
experimental
conditions
(e.g.,
sequences,
endpoints,
cell
lines,
buffers,
assays).
A
virtual
screening
with
G4-QuadScreen
molecular
docking
YASARA
(AutoDock-Vina)
was
performed.
activities
confirmed
via
FRET
melting,
FID,
viability
assays.
Validation
metrics
demonstrated
high
discriminatory
power
robustness
(the
accuracy
all
is
~>90%
training
sets
~>80%
external
sets).
evaluations
showed
that
ten
screened
have
capacity
to
selectively
stabilize
multiple
Three
induced
strong
inhibitory
effect
various
human
cancer
lines.
This
pioneering
serves
accelerate
search
new
leads
G4s,
reducing
false
positive
outcomes
early
stages
drug
discovery.
accessible
ChemoPredictionSuite
website.
Advanced Materials,
Journal Year:
2023,
Volume and Issue:
unknown
Published: Aug. 24, 2023
Nucleic
acid
plays
a
crucial
role
in
countless
biological
processes.
Hence,
there
is
great
interest
its
detection
and
analysis
various
fields
from
chemistry,
biology,
to
medicine.
Nanoporous
crystalline
materials
exhibit
enormous
potential
as
an
effective
platform
for
nucleic
recognition
application.
These
have
highly
ordered
uniform
pore
structures,
well
adjustable
surface
chemistry
size,
making
them
good
carriers
extraction,
detection,
delivery.
In
this
review,
the
latest
developments
nanoporous
materials,
including
metal
organic
frameworks
(MOFs),
covalent
(COFs),
supramolecular
(SOFs)
applications
are
discussed.
Different
strategies
functionalizing
these
explored
specifically
identify
targets.
Their
selective
separation
of
acids
highlighted.
They
can
also
be
used
DNA/RNA
sensors,
gene
delivery
agents,
host
DNAzymes,
DNA-based
computing.
Other
include
catalysis,
data
storage,
biomimetics.
The
development
novel
with
enhanced
biocompatibility
has
opened
up
new
avenues
therapy,
paving
way
sensitive,
selective,
cost-effective
diagnostic
therapeutic
tools
widespread
applications.
Artificial Intelligence Chemistry,
Journal Year:
2024,
Volume and Issue:
2(1), P. 100053 - 100053
Published: Feb. 6, 2024
RNA
molecules
play
multifaceted
functional
and
regulatory
roles
within
cells
have
garnered
significant
attention
in
recent
years
as
promising
therapeutic
targets.
With
remarkable
successes
achieved
by
artificial
intelligence
(AI)
different
fields
such
computer
vision
natural
language
processing,
there
is
a
growing
imperative
to
harness
AI's
potential
computer-aided
drug
design
(CADD)
discover
novel
compounds
that
target
RNA.
Although
machine-learning
(ML)
approaches
been
widely
adopted
the
discovery
of
small
targeting
proteins,
application
ML
model
interactions
between
molecule
still
its
infancy.
Compared
protein-targeted
discovery,
major
challenges
ML-based
RNA-targeted
stem
from
scarcity
available
data
resources.
interest
development
curated
databases
focusing
on
molecule,
field
anticipates
rapid
growth
opening
new
avenue
for
disease
treatment.
In
this
review,
we
aim
provide
an
overview
advancements
computationally
modeling
RNA-small
context
with
particular
emphasis
methodologies
employing
techniques.
Chemical Reviews,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 5, 2024
The
vast
majority
of
the
human
genome
codes
for
RNA,
but
RNA-targeting
therapeutics
account
a
small
fraction
approved
drugs.
As
such,
there
is
great
incentive
to
improve
old
and
develop
new
approaches
RNA
targeting.
For
many
targeting
modalities,
just
binding
not
sufficient
exert
therapeutic
effect;
thus,
targeted
degradation
induced
decay
emerged
as
powerful
with
pronounced
biological
effect.
This
review
covers
origins
advanced
use
cases
degrader
technologies
grouped
by
nature
modality
well
mode
degradation.
It
both
well-established
methods
clinically
successful
platforms
such
interference,
emerging
recruitment
quality
control
machinery,
CRISPR,
direct
We
also
share
our
thoughts
on
biggest
hurdles
in
this
field,
possible
ways
overcome
them.
RNA,
Journal Year:
2023,
Volume and Issue:
29(4), P. 473 - 488
Published: Jan. 24, 2023
RNA
structures
regulate
a
wide
range
of
processes
in
biology
and
disease,
yet
small
molecule
chemical
probes
or
drugs
that
can
modulate
these
functions
are
rare.
Machine
learning
other
computational
methods
well
poised
to
fill
gaps
knowledge
overcome
the
inherent
challenges
targeting,
such
as
dynamic
nature
difficulty
obtaining
high-resolution
structures.
Successful
tools
date
include
principal
component
analysis,
linear
discriminate
k-nearest
neighbor,
artificial
neural
networks,
multiple
regression,
many
others.
Employment
has
revealed
critical
factors
for
selective
recognition
RNA:small
complexes,
predictable
differences
RNA-
protein-binding
ligands,
quantitative
structure
activity
relationships
allow
rational
design
molecules
given
target.
Herein
we
present
our
perspective
on
value
using
machine
computation
advance
including
select
examples
their
validation
necessary
promising
future
directions
will
be
key
accelerate
discoveries
this
important
field.
Patterns,
Journal Year:
2024,
Volume and Issue:
5(1), P. 100909 - 100909
Published: Jan. 1, 2024
MicroRNAs
are
recognized
as
key
drivers
in
many
cancers
but
targeting
them
with
small
molecules
remains
a
challenge.
We
present
RiboStrike,
deep-learning
framework
that
identifies
against
specific
microRNAs.
To
demonstrate
its
capabilities,
we
applied
it
to
microRNA-21
(miR-21),
known
driver
of
breast
cancer.
ensure
selectivity
toward
miR-21,
performed
counter-screens
miR-122
and
DICER.
Auxiliary
models
were
used
evaluate
toxicity
rank
the
candidates.
Learning
from
various
datasets,
screened
pool
nine
million
identified
eight,
three
which
showed
anti-miR-21
activity
both
reporter
assays
RNA
sequencing
experiments.
Target
these
compounds
was
assessed
using
microRNA
profiling
analysis.
The
top
candidate
tested
xenograft
mouse
model
cancer
metastasis,
demonstrating
significant
reduction
lung
metastases.
These
results
RiboStrike's
ability
nominate
target
miRNAs
ACS Medicinal Chemistry Letters,
Journal Year:
2024,
Volume and Issue:
15(6), P. 814 - 821
Published: May 2, 2024
RNAs
are
increasingly
considered
valuable
therapeutic
targets,
and
the
development
of
methods
to
identify
validate
both
RNA
targets
ligands
is
more
important
than
ever.
Here,
we
utilized
a
bioinformatic
approach
hairpin-containing
G-quadruplex
(rG4)
in
5'
untranslated
region
(5'
UTR)
DHX15
mRNA.
By
using
novel
competitive
small
molecule
microarray
(SMM)
approach,
identified
compound
that
specifically
binds
rG4
(K
D
=
12.6
±
1.0
μM).
This
directly
impacts
translation
reporter
mRNA
vitro,
binding
our
(F1)
structure
inhibits
up
57%
(IC50
22.9
3.8
methodology
allowed
us
target
cancer-relevant
helicase
with
no
known
inhibitors.
Our
identification
method
novelty
screening
make
work
informative
for
future
cancer
therapeutics
targets.
Life,
Journal Year:
2025,
Volume and Issue:
15(1), P. 104 - 104
Published: Jan. 15, 2025
The
diversity
and
complexity
of
RNA
include
sequence,
secondary
structure,
tertiary
structure
characteristics.
These
elements
are
crucial
for
RNA's
specific
recognition
other
molecules.
With
advancements
in
biotechnology,
RNA-ligand
structures
allow
researchers
to
utilize
experimental
data
uncover
the
mechanisms
complex
interactions.
However,
determining
these
complexes
experimentally
can
be
technically
challenging
often
results
low-resolution
data.
Many
machine
learning
computational
approaches
have
recently
emerged
learn
multiscale-level
features
predict
Predicting
interactions
remains
an
unexplored
area.
Therefore,
studying
is
essential
understanding
biological
processes.
In
this
review,
we
analyze
interaction
characteristics
by
examining
structure.
Our
goal
clarify
how
specifically
recognizes
ligands.
Additionally,
systematically
discuss
methods
predicting
guide
future
research
directions.
We
aim
inspire
creation
more
reliable
prediction
tools.
Proceedings of the National Academy of Sciences,
Journal Year:
2025,
Volume and Issue:
122(17)
Published: April 22, 2025
RNAs
are
critical
regulators
of
gene
expression,
and
their
functions
often
mediated
by
complex
secondary
tertiary
structures.
Structured
regions
in
RNA
can
selectively
interact
with
small
molecules—via
well-defined
ligand-binding
pockets—to
modulate
the
regulatory
repertoire
an
RNA.
The
broad
potential
to
biological
function
intentionally
via
RNA–ligand
interactions
remains
unrealized,
however,
due
challenges
identifying
compact
motifs
ability
bind
ligands
good
physicochemical
properties
(often
termed
drug-like).
Here,
we
devise
fpocketR
,
a
computational
strategy
that
accurately
detects
pockets
capable
binding
drug-like
Remarkably
few,
roughly
50,
such
have
ever
been
visualized.
We
experimentally
confirmed
ligandability
novel
detected
using
fragment-based
approach
introduced
here,
Frag-MaP,
sites
cells.
Analysis
validated
Frag-MaP
reveals
dozens
able
ligands,
supports
model
for
structural
quality
creates
framework
understanding
ligand-ome.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Feb. 2, 2024
Abstract
The
possibility
of
using
RNA-targeting
small
molecules
to
treat
diseases
is
gaining
traction
as
the
next
frontier
drug
discovery
and
development.
chemical
characteristics
that
bind
RNA
are
still
relatively
poorly
understood,
particularly
in
comparison
protein-targeting
molecules.
To
fill
this
gap,
we
have
generated
an
unprecedented
amount
RNA-small
molecule
binding
data,
used
it
derive
physicochemical
rules
thumb
could
be
define
areas
space
enriched
for
binders
-
Small
Targeting
(STaR)
thumb.
These
been
applied
publicly
available
datasets
found
largely
generalizable.
Furthermore,
a
number
patented
compounds
FDA-approved
also
pass
these
rules,
well
key
approved
case
studies
including
Risdiplam.
We
anticipate
work
will
significantly
accelerate
exploration
RNA-targeted
space,
towards
unlocking
RNA’s
potential
target.
Graphical
Biochemistry and Cell Biology,
Journal Year:
2023,
Volume and Issue:
102(1), P. 9 - 27
Published: Aug. 14, 2023
Long
non-coding
RNAs
(lncRNAs)
are
significant
contributors
in
maintaining
genomic
integrity
through
epigenetic
regulation.
LncRNAs
can
interact
with
chromatin-modifying
complexes
both